We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Greenlights Barr's $2.5B Takeover Of Pliva

Law360 (December 11, 2006, 12:00 AM EST) -- The U.S. Federal Trade Commission has signed off on Barr Pharmaceuticals’ $2.5 billion acquisition of European generic drug giant Pliva on the condition that Barr sell the rights to four of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.